These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4967029)

  • 1. Increase of nonspecific resistance to infection by protodyne, a protein component derived from bacterial protoplasm.
    Berger FM; Fukui GM; Ludwig BJ; Rosselet JP
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):556-9. PubMed ID: 4967029
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of resistance to bacterial infections of mice with poly I-poly C.
    Weinstein MJ; Waitz JA; Came PE
    Nature; 1970 Apr; 226(5241):170. PubMed ID: 4908373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protective effect of the mushroom polysaccharide Schizophyllan against experimental bacterial infections].
    Komatsu N; Nagumo N; Okubo S; Koike K
    Jpn J Antibiot; 1973 Jun; 26(3):277-83. PubMed ID: 4270095
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of protodyne-induced protection against microbial infections.
    Berger FM; Fukui GM; Gustafson RH; Rosselet JP
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):391-5. PubMed ID: 4330232
    [No Abstract]   [Full Text] [Related]  

  • 5. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open and closed treatment of burns with povidone-iodine.
    Georgiade NG; Harris WA
    Plast Reconstr Surg; 1973 Dec; 52(6):640-4. PubMed ID: 4202393
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological investigations in experimental chemotherapy. 3. The initial period of low resistance in bacterial infections of mice in relation to bacteriostatic chemotherapy.
    Sackmann W
    Chemotherapia (Basel); 1968; 13(5):276-88. PubMed ID: 4889161
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical antibiotic prophylaxis in contaminated wounds. Experimental evaluation.
    Glotzer DJ; Goodman WS; Geronimus LH
    Arch Surg; 1970 May; 100(5):589-93. PubMed ID: 4314618
    [No Abstract]   [Full Text] [Related]  

  • 9. Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis.
    Houba V; Berger FM; Dinarello CA; Johnson AG; Le J; Mauël J; Van der Meer JW; Philippeaux MM; Vilcek J; Vogels MT
    Dev Biol Stand; 1992; 77():121-8. PubMed ID: 1426652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-free biologically active component of Escherichia coli.
    Rosselet JP; Murphy SG; Adamski RJ; Fletcher MJ; Ludwig BJ
    J Bacteriol; 1969 May; 98(2):434-6. PubMed ID: 4891255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotracheal gentamicin for the prevention of bronchial infections in patients with tracheotomy.
    Klastersky J; Cappel R; Noterman J; Snoeck J; Geuning C; Mouawad E
    Int J Clin Pharmacol; 1973 Jul; 7(4):279-86. PubMed ID: 4199250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapeutic action of quinozaline derivatives and N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Elina AS; Pershin GN; Tsyrul'nikova LG; Belozerova KA
    Farmakol Toksikol; 1967; 30(5):617-26. PubMed ID: 4877416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intensive care following organ transplantation under aseptic conditions].
    Pichlmaier H; Jabour A; Besirsky HW; Kanz E; Linke K; Altmeyer B; Edel HH; Müller R
    Bruns Beitr Klin Chir (1971); 1968 Mar; 216(2):122-32. PubMed ID: 4875850
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies, in the field, of a polyvalent vaccine against pulmonary infections in cattle].
    Rossi C
    Prog Immunobiol Stand; 1971; 5():319-23. PubMed ID: 4573942
    [No Abstract]   [Full Text] [Related]  

  • 15. NDM-1: the newest superbug?
    Patel S
    Nursing; 2012 Apr; 42(4):67-8. PubMed ID: 22456221
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R
    PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE EFFECT OF STREPTOCOCCAL ALLERGEN ON THE COURSE OF THE SHWARTZMAN PHENOMENON].
    MINERVIN SM; IAROSHIK LI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Oct; 40():12-7. PubMed ID: 14134918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiology and prevention of infections with potentially pathogenic bacteria].
    Teodorovici G; Bercovici C; Zvorişteanu V
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):777-83. PubMed ID: 4990789
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunogenic properties of a protective staphylococcal antigen].
    Akatov AK; Tolovskaia KR
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):107-12. PubMed ID: 4938659
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
    Kollonitsch J; Barash L; Kahan FM; Kropp H
    Nature; 1973 Jun; 243(5406):346-7. PubMed ID: 4147634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.